Publications

Year of Publication Titlesort descending Faculty Association
2017 Sex and Race Differences in the Association Between Statin Use and the Incidence of Alzheimer Disease. Roberta Diaz Brinton, Ph.D
2016 Sex biology contributions to vulnerability to Alzheimer's disease: A think tank convened by the Women's Alzheimer's Research Initiative. Roberta Diaz Brinton, Ph.D
2017 Sex differences in Alzheimer risk: Brain imaging of endocrine vs chronologic aging. Roberta Diaz Brinton, Ph.D
2016 Sex differences in metabolic aging of the brain: insights into female susceptibility to Alzheimer's disease. Roberta Diaz Brinton, Ph.D
2011 Shift in brain metabolism in late onset Alzheimer's disease: implications for biomarkers and therapeutic interventions. Roberta Diaz Brinton, Ph.D
2015 Spinal dopaminergic projections control the transition to pathological pain plasticity via a D1/D5-mediated mechanism. Patrick W Mantyh
2010 Spinal or systemic TY005, a peptidic opioid agonist/neurokinin 1 antagonist, attenuates pain with reduced tolerance. Tally Largent-Milnes, PhD, Frank Porreca, PhD, Todd Vanderah, PhD
2014 Src-mediated post-translational regulation of endoglin stability and function is critical for angiogenesis. Nam Lee, Ph.D.
2014 Structure-activity relationships of non-opioid [des-Arg(7)]-dynorphin A analogues for bradykinin receptors. Yeon Sun Lee, Frank Porreca, PhD
2012 Structure-activity relationships of trimethoxybenzyl piperazine N-type calcium channel inhibitors. Frank Porreca, PhD, Todd Vanderah, PhD
2016 Structure-Activity Relationships of [des-Arg(7)]Dynorphin A Analogues at the κ Opioid Receptor. Victor Hruby, Ph.D., Tally Largent-Milnes, PhD, Yeon Sun Lee, Frank Porreca, PhD, John M. Streicher, PhD, Todd Vanderah, PhD
2010 Sustained morphine-mediated pain sensitization and antinociceptive tolerance are blocked by intrathecal treatment with Raf-1-selective siRNA. Tally Largent-Milnes, PhD, Todd Vanderah, PhD
2017 Synergistic attenuation of chronic pain using mu opioid and cannabinoid receptor 2 agonists. Mohab M. Ibrahim, PhD, MD, Tally Largent-Milnes, PhD, Todd Vanderah, PhD
2011 Synthesis and biological evaluation of new opioid agonist and neurokinin-1 antagonist bivalent ligands. Victor Hruby, Ph.D., Josephine Lai , Ph.D., Frank Porreca, PhD, Todd Vanderah, PhD, Eva Varga, Ph.D.
2014 Synthesis and evaluation of bivalent ligands for binding to the human melanocortin-4 receptor. Yeon Sun Lee
2011 Synthesis of conolidine, a potent non-opioid analgesic for tonic and persistent pain. John M. Streicher, PhD
2012 Tachykinin NK₁ receptor antagonist co-administration attenuates opioid withdrawal-mediated spinal microglia and astrocyte activation. Victor Hruby, Ph.D., Tally Largent-Milnes, PhD, Todd Vanderah, PhD, Eva Varga, Ph.D.
2017 Targeting a Potassium Channel/Syntaxin Interaction Ameliorates Cell Death in Ischemic Stroke. Rajesh Khanna
2011 Targeting mitochondrial bioenergetics for Alzheimer's prevention and treatment. Roberta Diaz Brinton, Ph.D
2015 Targeting the prodromal stage of Alzheimer's disease: bioenergetic and mitochondrial opportunities. Roberta Diaz Brinton, Ph.D
2017 Targeting the S1P/S1PR1 axis mitigates cancer-induced bone pain and neuroinflammation. Tally Largent-Milnes, PhD, Todd Vanderah, PhD
2015 Targeting transporters: promoting blood-brain barrier repair in response to oxidative stress injury. Thomas P Davis, PhD, Patrick T Ronaldson, PhD
2015 Temperature differentially facilitates spontaneous but not evoked glutamate release from cranial visceral primary afferents. Tally Largent-Milnes, PhD
2012 Tempol modulates changes in xenobiotic permeability and occludin oligomeric assemblies at the blood-brain barrier during inflammatory pain. Thomas P Davis, PhD, Jeffrey J. Lochhead, PhD, Patrick T Ronaldson, PhD
2017 TGF-β triggers rapid fibrillogenesis via a novel TβRII-dependent fibronectin-trafficking mechanism. Nam Lee, Ph.D.

Pages